Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Long-term results confirm clinical research led by radiation oncologists at the Princess Margaret that adding radiotherapy to the treatment of men who have high-risk prostate cancer improves survival.
These results were published Feb. 17 in the
Journal of Clinical Oncology.
Adding radiotherapy to long-term hormone therapy halved the risk of men dying from prostate cancer within eight years. These results confirm the findings of an interim analysis that was published in the
Lancet in 2011, says Dr. Padraig Warde, principal investigator.
"In 2011, based on the interim findings, we concluded that adding radiation to the treatment plan should become part of the standard therapy," says Dr. Warde. "It's excellent to know that the benefit of combining radiation and hormone therapy is maintained over the long-term. This provides real hope – and quality of life – for men fighting this disease."
Between 1995 and 2005, the clinical trial recruited 1,205 patients with locally-advanced prostate cancer that had grown outside the surface of the prostate but had not spread further. Half were treated with hormone therapy and the other half were treated with a combination of hormone therapy and radiotherapy.